TAOX Q4 2024 Earnings EPS Misses Estimates Amid Operational Challenges Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Pipeline Development Amicus Therapeutics FOLD Q4 2025 Earnings EPS Falls Far Short of Estimates Amid Thin Operational Detail Haemonetics Q1 2026 Earnings EPS Slightly Above Estimates Stock Gains 57 MTRX Q1 2026 Earnings Strong EPS Beat Signals Operational Momentum AAON Q1 2026 Earnings EPS Surges Past Estimates with 62 Beat